Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man
- PMID: 2574673
- DOI: 10.1007/BF00558500
Effect of urinary pH on the plasma and urinary kinetics of remoxipride in man
Abstract
The influence of urinary pH on the plasma and urinary kinetics of remoxipride in man has been studied in an open crossover trial in ten healthy male volunteers. Ammonium chloride (urinary pH 5.2) and sodium hydrogen carbonate (urinary pH 7.8) were used as pretreatments on two occasions in randomized order. On each occasion remoxipride 50 mg solution was administered orally and plasma and urinary concentrations of the drug were determined by HPLC and plasma prolactin concentrations by RIA. Remoxipride was rapidly distributed in the body according to a one-compartment model. The mean plasma elimination half-life (t1/2) was 3.6 h in the ammonium chloride experiment and 6.2 h in the sodium hydrogen carbonate experiment. The mean plasma clearance of remoxipride was 141 and 89.9 ml.min-1 in the acidic and alkaline conditions, respectively, and the corresponding mean renal clearances were 58.5 ml.min-1 and 11.7 ml.min-1. The urinary excretion of remoxipride up to 72 h after drug administration was 43.1% and 12.3% following acidification and alkalinization, respectively. Remoxipride induced a similar rapid, transient elevation of plasma prolactin under both conditions. Thus, the urinary pH has a marked effect on the elimination kinetics of remoxipride. After an overdose, treatment with ammonium chloride might be valuable in hastening elimination of remoxipride from the body.
Similar articles
-
Remoxipride: pharmacokinetics and effect on plasma prolactin.Br J Clin Pharmacol. 1991 Sep;32(3):355-60. doi: 10.1111/j.1365-2125.1991.tb03911.x. Br J Clin Pharmacol. 1991. PMID: 1685665 Free PMC article. Clinical Trial.
-
Remoxipride--a new potential antipsychotic compound. Tolerability and pharmacokinetics after single oral and intravenous administration in healthy male volunteers.Psychopharmacology (Berl). 1989;98(3):304-9. doi: 10.1007/BF00451679. Psychopharmacology (Berl). 1989. PMID: 2568653
-
Effect of urinary pH on the disposition of methadone in man.Eur J Clin Pharmacol. 1982;22(4):337-42. doi: 10.1007/BF00548403. Eur J Clin Pharmacol. 1982. PMID: 6286317
-
Clinical pharmacokinetics of remoxipride.Acta Psychiatr Scand Suppl. 1990;358:41-4. doi: 10.1111/j.1600-0447.1990.tb05284.x. Acta Psychiatr Scand Suppl. 1990. PMID: 1978486 Review.
-
[Remoxipride, a selective antagonist of dopamine D2 receptors, in the treatment of delusional psychoses].Encephale. 1990 Mar-Apr;16(2):153-7. Encephale. 1990. PMID: 1972054 Review. French.
Cited by
-
Remoxipride. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in schizophrenia.Drugs. 1990 Dec;40(6):863-79. doi: 10.2165/00003495-199040060-00008. Drugs. 1990. PMID: 1981869 Review.
-
The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function.Br J Clin Pharmacol. 1993 Jun;35(6):615-22. doi: 10.1111/j.1365-2125.1993.tb04191.x. Br J Clin Pharmacol. 1993. PMID: 8329289 Free PMC article.
-
Remoxipride: pharmacokinetics and effect on plasma prolactin.Br J Clin Pharmacol. 1991 Sep;32(3):355-60. doi: 10.1111/j.1365-2125.1991.tb03911.x. Br J Clin Pharmacol. 1991. PMID: 1685665 Free PMC article. Clinical Trial.
-
Pharmacology of the atypical antipsychotic remoxipride, a dopamine D2 receptor antagonist.CNS Drug Rev. 2001 Fall;7(3):265-82. doi: 10.1111/j.1527-3458.2001.tb00199.x. CNS Drug Rev. 2001. PMID: 11607043 Free PMC article. Review.
-
Pharmacokinetics and effects on prolactin of remoxipride in patients with tardive dyskinesia.Psychopharmacology (Berl). 1991;103(1):46-9. doi: 10.1007/BF02244072. Psychopharmacology (Berl). 1991. PMID: 1672458
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous